Fate Therapeutics Inc (FATE) Insider Trading
- $140,338,122.89
- $85,937,046.68
- Aug. 6, 2024
- J Scott Wolchko
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 10, 2014 | Insider | 3,305 | $7.00 | Sell | $23,135.00 | |
| May 1, 2014 | Insider | 9,793 | $7.07 | Sell | $69,236.51 | |
| April 4, 2014 | Insider | 5,889 | $8.00 | Sell | $47,112.00 | |
| April 2, 2014 | Insider | 10,000 | $9.02 | Sell | $90,200.00 | |
| April 1, 2014 | Insider | 20,000 | $9.64 | Sell | $192,800.00 | |
| March 31, 2014 | CTO | 8,653 | $9.86 | Sell | $85,318.58 | |
| Oct. 4, 2013 | Major Shareholder | 833,333 | $6.00 | Buy | $4,999,998.00 | |
| Oct. 4, 2013 | Director | 16,667 | $6.00 | Buy | $100,002.00 |
Insiders are both buying and selling Fate Therapeutics Inc stock.
The insider traders at Fate Therapeutics Inc are: J Scott Wolchko, Cindy Tahl, Amir Nashat, Bahram Valamehr, Edward J Dulac III, Redmile Group, Llc, Daniel D Shoemaker, Yu-Waye Chu, John Mendlein, Peter D Flynn, Yuan Xu, Chris Storgard, Brian T Powl, Shefali Agarwal, Valamehr Bahram, Venture Fund Vi Lp Arch, William H Rastetter, Mark Plavsic, and Christian Weyer
The most active insider trader at Fate Therapeutics Inc is J Scott Wolchko with 22 trades.
J Scott Wolchko has sold the most Fate Therapeutics Inc stock with a total value of $38,805,080.89.
Redmile Group, Llc has bought the most Fate Therapeutics Inc stock with a total value of $133,606,012.88.
The most recent insider trade for Fate Therapeutics Inc was on Aug. 6, 2024.
The single biggest insider buy for Fate Therapeutics Inc was from Redmile Group, Llc with a total value of $50,000,004.00 on Sept. 25, 2018.
The single biggest insider sell for Fate Therapeutics Inc was from J Scott Wolchko with a total value of $8,074,116.31 on Jan. 11, 2021.